Liu X - Search Results

1

Identification of EGFR-Related LINC00460/mir-338-3p/MCM4 Regulatory Axis as Diagnostic and Prognostic Biomarker of Lung Adenocarcinoma Based on Comprehensive Bioinformatics Analysis and Experimental Validation.

Jia M, Feng S, Cao F, Deng J, Li W, Zhou W, Liu X, Bai W. Jia M, et al. Among authors: liu x. Cancers (Basel). 2022 Oct 17;14(20):5073. doi: 10.3390/cancers14205073. Cancers (Basel). 2022. PMID: 36291859 Free PMC article.

2

Prognostic predictors of remission in ocular myasthenia after thymectomy.

Liu X, Zhou W, Hu J, Hu M, Gao W, Zhang S, Zeng W. Liu X, et al. J Thorac Dis. 2020 Mar;12(3):422-430. doi: 10.21037/jtd.2020.01.17. J Thorac Dis. 2020. PMID: 32274108 Free PMC article.

3

Comprehensive Analysis of CDK1-Associated ceRNA Network Revealing the Key Pathways LINC00460/LINC00525-Hsa-Mir-338-FAM111/ZWINT as Prognostic Biomarkers in Lung Adenocarcinoma Combined with Experiments.

Li W, Feng SS, Wu H, Deng J, Zhou WY, Jia MX, Shi Y, Ma L, Zeng XX, Zuberi Z, Fu D, Liu X, Chen Z. Li W, et al. Among authors: liu x. Cells. 2022 Apr 4;11(7):1220. doi: 10.3390/cells11071220. Cells. 2022. PMID: 35406786 Free PMC article.

4

Let-7c-5p Restrains Cell Growth and Induces Apoptosis of Lung Adenocarcinoma Cells via Targeting ESPL1.

Liu X, Zeng W, Zheng D, Tang M, Zhou W. Liu X, et al. Mol Biotechnol. 2022 Dec;64(12):1367-1375. doi: 10.1007/s12033-022-00511-2. Epub 2022 May 31. Mol Biotechnol. 2022. PMID: 35639278

5

Clinical significance of securin expression in solid cancers: A PRISMA-compliant meta-analysis of published studies and bioinformatics analysis based on TCGA dataset.

Liu X, Zeng W, Zheng D, Tang M, Zhou W. Liu X, et al. Medicine (Baltimore). 2022 Sep 16;101(37):e30440. doi: 10.1097/MD.0000000000030440. Medicine (Baltimore). 2022. PMID: 36123907 Free PMC article.

6

Construction of a prognostic model for lung adenocarcinoma based on heat shock protein-related genes and immune analysis.

Zhou W, Zeng W, Zheng D, Yang X, Qing Y, Zhou C, Liu X. Zhou W, et al. Among authors: liu x. Cell Stress Chaperones. 2023 Nov;28(6):821-834. doi: 10.1007/s12192-023-01374-5. Epub 2023 Sep 11. Cell Stress Chaperones. 2023. PMID: 37691069 Free PMC article.

7

[No title available]

[No authors listed] [No authors listed] PMID: 38225023

8

TFAP2A Upregulates SKA3 to Promote Glycolysis and Reduce the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin.

Liu G, Liu X, Zeng W, Zhou W. Liu G, et al. Among authors: liu x. Pharmacology. 2024;109(4):202-215. doi: 10.1159/000536557. Epub 2024 Apr 22. Pharmacology. 2024. PMID: 38643755

9

BATF-Activated AIM2 Mediates Immune Escape in Lung Adenocarcinoma by Regulating PD-L1.

Liu X, Zhou W, Zheng D, Yang X, Qing Y, Liao W, Zeng W. Liu X, et al. Int Arch Allergy Immunol. 2024 Oct 29:1-13. doi: 10.1159/000540875. Online ahead of print. Int Arch Allergy Immunol. 2024. PMID: 39471785

10

A Risk Model Based on Sorafenib-Response Target Genes Predicts the Prognosis of Patients with HCC.

Liu X, Zeng J, Li H, Li F, Jiang B, Zhao M, Liu Z, Li R, Ma T. Liu X, et al. Among authors: liu z. J Oncol. 2022 Jun 28;2022:7257738. doi: 10.1155/2022/7257738. eCollection 2022. J Oncol. 2022. PMID: 35799605 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137,755 results

Search Page

Filters